Received: from CY8PR07MB9594.namprd07.prod.outlook.com (2603:10b6:930:56::5)
 by DM8PR07MB8949.namprd07.prod.outlook.com with HTTPS; Tue, 2 Apr 2024
 23:11:18 +0000
Received: from BY3PR10CA0019.namprd10.prod.outlook.com (2603:10b6:a03:255::24)
 by CY8PR07MB9594.namprd07.prod.outlook.com (2603:10b6:930:56::5) with
 Microsoft SMTP Server (version=TLS1_2,
 cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.20.7409.46; Tue, 2 Apr
 2024 23:11:15 +0000
Received: from DS1PEPF00017094.namprd03.prod.outlook.com
 (2603:10b6:a03:255:cafe::db) by BY3PR10CA0019.outlook.office365.com
 (2603:10b6:a03:255::24) with Microsoft SMTP Server (version=TLS1_2,
 cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.20.7409.46 via Frontend
 Transport; Tue, 2 Apr 2024 23:11:15 +0000
Authentication-Results: spf=pass (sender IP is 209.85.221.172)
 smtp.mailfrom=gmail.com; dkim=pass (signature was verified)
 header.d=gmail.com;dmarc=pass action=none header.from=gmail.com;compauth=pass
 reason=100
Received-SPF: Pass (protection.outlook.com: domain of gmail.com designates
 209.85.221.172 as permitted sender) receiver=protection.outlook.com;
 client-ip=209.85.221.172; helo=mail-vk1-f172.google.com; pr=C
Received: from mail-vk1-f172.google.com (209.85.221.172) by
 DS1PEPF00017094.mail.protection.outlook.com (10.167.17.137) with Microsoft
 SMTP Server (version=TLS1_3, cipher=TLS_AES_256_GCM_SHA384) id 15.20.7452.22
 via Frontend Transport; Tue, 2 Apr 2024 23:11:15 +0000
Received: by mail-vk1-f172.google.com with SMTP id 71dfb90a1353d-4affeacaff9so1558870e0c.3;
        Tue, 02 Apr 2024 16:11:15 -0700 (PDT)
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed;
        d=gmail.com; s=20230601; t=1712099474; x=1712704274; darn=gatech.edu;
        h=cc:to:subject:message-id:date:from:in-reply-to:references
         :mime-version:from:to:cc:subject:date:message-id:reply-to;
        bh=zmMRZW4J6sElFOa1+VBx1QLpQyXvx9r1kE4Xmr4vBVg=;
        b=LrM1I53uB25XmKpofyi78XcPXNKlx0DAr1InPG/Po8mRiNgtnEEq0kMYJTbYcbdk3q
         quT2AyIvHBARtCNCGYd1XlLjGIy5LwdC2l3QqN+PwdMHGliM2O/MHLDRWV5Vtyp2Byd7
         Qr7Rdzhk2WKy3boPoLkPBbIWiw7VfFnHTzHkI8jV7Pghn9FCKzaZnFLYeGid53QtS94d
         cOAUHH4H4AYq+EWRV4B9kPf2Qfp3VqslLNgicMenGCkD4p3Wj14jHHDtx3pyr/hvcvBZ
         LVzNCdpQynsANwfDOgLF4Vfh78rC0Lm158UjDNXv3OUYcAsFaCVNqDbWldhhpad1PHC3
         W/1g==
X-Google-DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed;
        d=1e100.net; s=20230601; t=1712099474; x=1712704274;
        h=cc:to:subject:message-id:date:from:in-reply-to:references
         :mime-version:x-gm-message-state:from:to:cc:subject:date:message-id
         :reply-to;
        bh=zmMRZW4J6sElFOa1+VBx1QLpQyXvx9r1kE4Xmr4vBVg=;
        b=e7t88QmtHV2sG+doMVYSuPqSFQiRNQ2EBzEmu/e3QlZdMenx7XxLOfEnD62JHRLBNM
         nP/i4AIUwoBiqbA9mPHuW9pM53I6VFe9mk3buysVYS58TlH8bocmAF6ZyPqVTw2JIJeS
         Idsq3U8FgpAOIJwflKYcfH6OOzqXraeaN5ALAB7f8Jclocdu93T663RDIWcMbvAH3Ewc
         FurNNKfbsV0UDe5jwm4PZK4RaJ/aFue3kbIAqkf5Z4w7Eu8Y192OysRIXHQmf68iF7Sx
         1PvQtSa8/LFXRNGOOCDDUaxF0rXWtum5l5Yd6ZianSFOVyvgI5lgSi+LS7KFXGF9T5X+
         bQqA==
X-Forwarded-Encrypted: i=1; AJvYcCXsuKRQuNky7kIjBWLXTBvStQNjDT15j2BPmkKHDS3MqI8TN0SLxPneTCV6w8OdelgHR2ktlnQBS6Yu9RohGluTnWP7zrW+SJ5Co8xxnP/RHU6XEHBqkcxfoDuNwDGmJB4P57l0amdzrq3TEg==
X-Gm-Message-State: AOJu0YxpsdVlXlJBBG+H7QSPf90K6MVdnfl7lxTXSr5deZu97bGYQJG3
	cnz5B1h1lXZ65m0dNUOfIxcxI6QiDiuzS12MGux9rL8Tc0AYmiwqF3YkhGfgfYE2YhIMg7S45/1
	3gsqKzv78eHUXB28hT3f2U26T7aiicv+c
X-Google-Smtp-Source: AGHT+IFwKyquGZ42qEZXuzplo7dTtTIZstlWx8eT5Cnym4l1/KyRSyXAlFJM77dGC9N/8n1uHKr6qIMbF2NID8m5P0Q=
X-Received: by 2002:a1f:fe4c:0:b0:4d8:37eb:9562 with SMTP id
 l73-20020a1ffe4c000000b004d837eb9562mr9457830vki.0.1712099474048; Tue, 02 Apr
 2024 16:11:14 -0700 (PDT)
References: <CO3PR07MB92396DC50ACF4C1B13A4BFCAFD5E2@CO3PR07MB9239.namprd07.prod.outlook.com>
 <CO3PR07MB92393B4B213630D54E168262FD5E2@CO3PR07MB9239.namprd07.prod.outlook.com>
In-Reply-To: <CO3PR07MB92393B4B213630D54E168262FD5E2@CO3PR07MB9239.namprd07.prod.outlook.com>
From: Muling Lin <mulingg@gmail.com>
Date: Tue, 2 Apr 2024 19:11:03 -0400
Message-ID: <CACi-ZaK+bc5AP8swchQUG1PdZZXpnYQdNuxizAgQ2D-aRWLA8w@mail.gmail.com>
Subject: Re: Heart Disease Care App Project Question
To: "Rogers, Jacob C" <jrogers335@gatech.edu>
Cc: "Storey, Edward C" <edward.storey@gatech.edu>, "Fu, Michael D" <mfu42@gatech.edu>, 
	"Avunuri, Sai Anoop" <savunuri3@gatech.edu>, "Song, Jaehoon" <jsong421@gatech.edu>
Content-Type: multipart/alternative; boundary="000000000000f88e1a06152538a3"
Return-Path: mulingg@gmail.com
X-MS-Exchange-Organization-ExpirationStartTime: 02 Apr 2024 23:11:15.1584
 (UTC)
X-MS-Exchange-Organization-ExpirationStartTimeReason: OriginalSubmit
X-MS-Exchange-Organization-ExpirationInterval: 1:00:00:00.0000000
X-MS-Exchange-Organization-ExpirationIntervalReason: OriginalSubmit
X-MS-Exchange-Organization-Network-Message-Id:
 cbd64576-795b-4aac-1879-08dc536a3214
X-EOPAttributedMessage: 0
X-EOPTenantAttributedMessage: 482198bb-ae7b-4b25-8b7a-6d7f32faa083:0
X-MS-Exchange-Organization-MessageDirectionality: Incoming
X-MS-PublicTrafficType: Email
X-MS-TrafficTypeDiagnostic:
 DS1PEPF00017094:EE_|CY8PR07MB9594:EE_|DM8PR07MB8949:EE_
X-MS-Exchange-Organization-AuthSource:
 DS1PEPF00017094.namprd03.prod.outlook.com
X-MS-Exchange-Organization-AuthAs: Anonymous
X-MS-Office365-Filtering-Correlation-Id: cbd64576-795b-4aac-1879-08dc536a3214
X-MS-Exchange-AtpMessageProperties: SA
X-GT-Tenant: 042d12d7-75fe-4547-b5b6-0573f80f829d
X-MS-Exchange-Organization-SCL: 1
X-Microsoft-Antispam: BCL:0;
X-Forefront-Antispam-Report:
 CIP:209.85.221.172;CTRY:US;LANG:en;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:mail-vk1-f172.google.com;PTR:mail-vk1-f172.google.com;CAT:NONE;SFS:(13230031);DIR:INB;
X-MS-Exchange-CrossTenant-OriginalArrivalTime: 02 Apr 2024 23:11:15.1584
 (UTC)
X-MS-Exchange-CrossTenant-Network-Message-Id: cbd64576-795b-4aac-1879-08dc536a3214
X-MS-Exchange-CrossTenant-Id: 482198bb-ae7b-4b25-8b7a-6d7f32faa083
X-MS-Exchange-CrossTenant-AuthSource:
 DS1PEPF00017094.namprd03.prod.outlook.com
X-MS-Exchange-CrossTenant-AuthAs: Anonymous
X-MS-Exchange-CrossTenant-FromEntityHeader: Internet
X-MS-Exchange-Transport-CrossTenantHeadersStamped: CY8PR07MB9594
X-MS-Exchange-Transport-EndToEndLatency: 00:00:02.9942010
X-MS-Exchange-Processed-By-BccFoldering: 15.20.7409.037
X-Microsoft-Antispam-Mailbox-Delivery:
	ucf:0;jmr:0;auth:0;dest:I;ENG:(910001)(944506478)(944626604)(920097)(930097)(140003);
X-Microsoft-Antispam-Message-Info:
	=?utf-8?B?aGM3SGZSYTRsb0dnYytxODAyLzF6dE5vWU5TNk5ybkRVdXBnVGhoMDNCRmJ3?=
 =?utf-8?B?VU50eHFNQ0RLb3dGSXJlOTVYM1IzZEhCMmpwWWZqV2lLMEszOFpiSkFYOFZo?=
 =?utf-8?B?NFFvUk1MK2I3M1dpM2pqb0FWVnRUYmJvQzJtM3VWNUJKTUJsZHN3WFppNnpB?=
 =?utf-8?B?YjZjdVlsKzZZTEtHYjhBUnY3cCtieTcrSU0vUUdYMnNoZlorcU5rSDROTUdz?=
 =?utf-8?B?Z1d4ZVVFYmtwcnpOZWRsaGFjUHVzWTBEVFF6V1BlOW84dVNGdzNkQWNUeEVJ?=
 =?utf-8?B?RndqU3lVYXkvNThOSjRMWUhEZm0zODRwWTlsRkhmdVFlSlptdlJCVG9kRlpi?=
 =?utf-8?B?by9oSldseHI0QzQ3SjJmVkd6NnYzYUFPcXhsVWU5VHJ4R2oxaTltbW5hdmx1?=
 =?utf-8?B?ZUFWUjhITlh6Vk9GVFJiS041b0ZpY2h2d0U1SEVYZmw2bTZiMEROMnhCRlJ4?=
 =?utf-8?B?ckUzS3pXcVFwVFBuVTc5R3lmWElPM2x1T0M2ME4wZEJ1anh6dVBzN29wRXRk?=
 =?utf-8?B?UVlsMlpvRVNnNm5LREt4bEtGZmJpc1hDRGRkNGZtZ3JwbzFXVUtxdVdORGJy?=
 =?utf-8?B?Q1hJWitmMXhscEFsZVhKSzBnUWp5K1RGbnBuaS9sbzBHTm5XblFnZGFBVy93?=
 =?utf-8?B?ZWRva0Z6KzFJRjF5cXhlcEdsMWptRDdoTVV4bGd3SUIvQVp5OENxWWZwQjRm?=
 =?utf-8?B?dTUxb2tFUHJadWNRdEZVRlZnNE5ab1hHUkxwTWRJajRrNDFtQVYyOGt0ZDZP?=
 =?utf-8?B?ZHlNT3hsTXloZk1KSFBlQ1VTUUdTS2xLUFN1Vmw3ejNUNmFCdGU1WTVUTG55?=
 =?utf-8?B?UldpY3lTVlpZaFZrOEN3UFIvaitSSXk4alBrdTFuRk5VT2Nsa3lTcVlpRnZq?=
 =?utf-8?B?T0FhYWpQRk1VZHBudEpTNzFUSTlyMkY1QjdTSHVkbW1JKzRQdzlNdjVZR3pl?=
 =?utf-8?B?T053cWpxbzJnbWorLzZ3U1ZQczdFZlNGa3ROYmRzdk9aNkpuUTc5K2QyQ1d5?=
 =?utf-8?B?VEVHLzdwSWtzLzlpVTFRQWR4VWNBZ0pXbjNuTXhHNExyYmtNaU4vVXpucHV6?=
 =?utf-8?B?RmN1ZmJMajZBR2IraHg5TUYvMU0wRllhU3JqNElRMURkZ3c3SjRoMGp2OFpk?=
 =?utf-8?B?aGZBM2Q1aFlOLzkxL2MvNEtkcUs0d0pmSndYbFhOZmRXbkhXR25CK3d3WjVV?=
 =?utf-8?B?bm8yK2pBMnA2aUE4aWoxa3JOayt3SVN1NWlQNVJYUkRpZVVReDFJVnozSDFq?=
 =?utf-8?B?MzJqeEZpQnUxb2dEbngwb3dnZGtqOVNaOGNaUEtWMkRSTVU1SUJmNmhVLzVq?=
 =?utf-8?B?UTd1NncwWWZqVTc5bEVIUndLaHdlYTRaZUpQMXp1bzhaVWlzdjJ6VTIrNmVL?=
 =?utf-8?B?Z01FWkpSb1BEc1IrRk5OT3YxV0RuZlNZejRTR0NYRnlCUGJZU0p6WlcySlhm?=
 =?utf-8?B?RE10dHorV1FRMlFRdTNlbEltOVBOTWRyUEY4YzZNa0J6TjlHZDF0UHJrY29h?=
 =?utf-8?B?dzJzR1A2b000eCsxbTBRaUUxVHVuQmJWdWNMOEdxZDBxUEg1Y2ZBblJJWFFo?=
 =?utf-8?B?emxsa2VKcWFkaUdjRmF1VU9ZcFR3VzA3M0R4clFaQ2dwR3lDeHJXZXZuN2pB?=
 =?utf-8?B?blRmbnhnbUd3ckI4Z2cyUlhTd2FoVERVR2Y4VjdGQjFpWUtaTFcrMUxlTkxP?=
 =?utf-8?B?MlZtUHAxR2Exd0ZFMU1sa1dDdk9QdUUwbTFjNnM5amR0V1NTanY1OE5OOWk5?=
 =?utf-8?B?UmJkMVJhQUlLWEVzOEpLZnMzR3FJSUF3V0pnZnRucmM1MlE5OEZnTWYwWjlQ?=
 =?utf-8?B?TzB0MkZNOThvd0NKYzIrS0ZDaFhqcUJ6T2t1ZTBPdEFtQWpiUFovWmhlekRQ?=
 =?utf-8?B?RU5XRGsyT2JXbzlLYmpFQVdUcS9ZUVRYOTNMV29sSjZmaGxVMyszbm1ONnpQ?=
 =?utf-8?B?Y2NyVEhCRzZMb2NMRXJoSDdJV0ZxNnZ4aU1rTDlyK2U4bHluYU1mdy9hdkhO?=
 =?utf-8?B?YWZMUGx2RDQvSUM2L1lPSWxkRkQyMk9tZTJISG4vQUZRb3RkN3UyVXowQ2FL?=
 =?utf-8?B?eDF5ZDZ6WW1uem03dXFXckFlb0JOS2tDRlBJVSsrOXdpeVd5aWU0Kzh6djE4?=
 =?utf-8?B?LzVVajlIbEExT1JacmlvdFJHYittcXF2V1RkL1JQTmNJSDkwb3ZYSmY4S3Q0?=
 =?utf-8?B?QVFFU0JKVWV1OUVjR2ZUZ29CdndGcUoyMGtVYXd3VGxZR0FHSGc5Vk1KLzd5?=
 =?utf-8?B?RlRvQW5mQldLUGFGZXd4Y2tnQlMxcHdyK0VjNlk4Qnp4QnUreXJFS3pMWmZL?=
 =?utf-8?B?akpuelhLOHpUbEI5WWtZbVZoeGY0S1JOeUlyRGZsdHRNbVYvbDU3OElOemJP?=
 =?utf-8?B?ZUF1QTc4RktNOTEvTHp1NUZreVUrSXZkMkxaSkNmQklScUtISGRNQ1c3YkVB?=
 =?utf-8?B?ZXFmN2lhVFEwMEpSRWYxVEJ6dTY5Yy9pTWFiTzVUNDVIdzdXb2h5dk5tTldu?=
 =?utf-8?B?T1p3Q1QvZTRVSVJVaWZtUnhlTFU2VEVLeUFJckFzekxBajdQTHBpYWV0cWxl?=
 =?utf-8?B?OGs5ZWZpYmVLMnFjQWVVekVBbjkyeTgzNmRnUENNb3NUbHNsQ0VBY0Rja3kx?=
 =?utf-8?Q?B7vn8g2L3IlG2KSocgzDZqNQAEmg=3D?=
MIME-Version: 1.0

--000000000000f88e1a06152538a3
Content-Type: text/plain; charset="UTF-8"
Content-Transfer-Encoding: quoted-printable

Hey Jacob and the rest of Team 3342,

Really sorry for the late response - I saw this a while back and was
planning on responding but it just got lost. Not sure if it is still
relevant at this point but everything you mentioned sounds excellent. The
only improvement I can think is if we are able to stratify patients into
different tabs/columns (green/yellow/red) so that it's easy for clinicians
to be more efficient in addressing the patients with the most urgent needs
without having the visual noise of the other colors intermingled with each
other.

I think the custom notifications is an interesting idea but I think a call
would still be best - there's a lot of medical information that would still
be best conveyed through a conversation. Good idea though! Let me know if
anything else comes up and again apologies for the delayed answer.

Best,
Muling


On Fri, Mar 1, 2024 at 5:31=E2=80=AFPM Rogers, Jacob C <jrogers335@gatech.e=
du>
wrote:

> Hi again,
>
> Sorry for  the double email but I just remembered we had one additional
> question for you regarding the whole system.
> In the medical staff dashboard, we plan on creating a system where the
> medical staff team can create custom notifications to send to patients'
> phones. Does this seem like a worthwhile addition to you, or is it
> redundant since the staff have access to the phone number of the patients
> which is also visible on the page?
>
> If you like this idea of the custom notifications, should the name of the
> staff member that send the notification be visible as part of the custom
> notification to the patient?
>
> Thanks again, and have a good weekend!
> Jacob
> ------------------------------
> *From:* Rogers, Jacob C <jrogers335@gatech.edu>
> *Sent:* Friday, March 1, 2024 5:27 PM
> *To:* mulingg@gmail.com <mulingg@gmail.com>
> *Cc:* Storey, Edward C <edward.storey@gatech.edu>; Fu, Michael D <
> mfu42@gatech.edu>; Avunuri, Sai Anoop <savunuri3@gatech.edu>; Song,
> Jaehoon <jsong421@gatech.edu>
> *Subject:* Heart Disease Care App Project Question
>
> Hi Muling,
>
> Happy March, hope you've had a good last week of February. This last
> sprint of the project we have been working to develop the medical staff
> dashboard and had a quick design question for you.
>
> In the main dashboard where the medical staff can see patients, we are
> implementing a priority feature where each patient is assigned a risk
> rating based on a statistical analysis model we are developing that notic=
es
> deviations in weight. For this system, we currently plan on implementing =
a
> three-tier system:
>
> Green (representing no detectable risk patterns)
> Yellow (representing some possible detected risk that should be reviewed
> by staff)
> Red (representing large, sudden deviation in weight or detected swelling)
>
> Each patient will have this color as a part of their information to
> improve the efficiency of the system and ensure higher risk patients are
> viewed by medical staff first. Does this system sound sufficient to you,
> and could you think of any improvements?
>
> More generally, our progress on the project is up to date with the
> iteration plan and development is going smoothly. We're excited to show y=
ou
> all the new features next time we meet.
>
> Thanks so much!
> Jacob for GT Junior Design Team 3342
>

--000000000000f88e1a06152538a3
Content-Type: text/html; charset="UTF-8"
Content-Transfer-Encoding: quoted-printable

<meta http-equiv=3D"Content-Type" content=3D"text/html; charset=3Dutf-8"><d=
iv dir=3D"ltr">Hey Jacob and the rest of Team 3342,<div><br></div><div>Real=
ly sorry for the&nbsp;late response - I saw this a while back and was plann=
ing on responding but it just got lost. Not sure if it is still relevant at=
 this point but everything you mentioned sounds excellent. The only improve=
ment I can think is if we are able to stratify patients into different tabs=
/columns (green/yellow/red) so that it's easy for clinicians to be more eff=
icient in addressing the patients with the most urgent needs without having=
 the visual noise of the other colors intermingled with each other.&nbsp;</=
div><div><br></div><div>I think the custom notifications is an interesting =
idea but I think a call would still be best - there's a lot of medical info=
rmation that would still be best conveyed through a conversation. Good idea=
 though! Let me know if anything else comes up and again apologies for the&=
nbsp;delayed answer.&nbsp;</div><div><br></div><div>Best,</div><div>Muling<=
/div><div><br></div></div><br><div class=3D"gmail_quote"><div dir=3D"ltr" c=
lass=3D"gmail_attr">On Fri, Mar 1, 2024 at 5:31=E2=80=AFPM Rogers, Jacob C =
&lt;<a href=3D"mailto:jrogers335@gatech.edu">jrogers335@gatech.edu</a>&gt; =
wrote:<br></div><blockquote class=3D"gmail_quote" style=3D"margin:0px 0px 0=
px 0.8ex;border-left:1px solid rgb(204,204,204);padding-left:1ex"><div clas=
s=3D"msg1823689867367682542">




<div dir=3D"ltr">
<div style=3D"font-family:Aptos,Aptos_EmbeddedFont,Aptos_MSFontService,Cali=
bri,Helvetica,sans-serif;font-size:12pt;color:rgb(0,0,0)">
Hi again,</div>
<div style=3D"font-family:Aptos,Aptos_EmbeddedFont,Aptos_MSFontService,Cali=
bri,Helvetica,sans-serif;font-size:12pt;color:rgb(0,0,0)">
<br>
</div>
<div style=3D"font-family:Aptos,Aptos_EmbeddedFont,Aptos_MSFontService,Cali=
bri,Helvetica,sans-serif;font-size:12pt;color:rgb(0,0,0)">
Sorry for&nbsp; the double email but I just remembered we had one additiona=
l question for you regarding the whole system.</div>
<div style=3D"font-family:Aptos,Aptos_EmbeddedFont,Aptos_MSFontService,Cali=
bri,Helvetica,sans-serif;font-size:12pt;color:rgb(0,0,0)">
In the medical staff dashboard, we plan on creating a system where the medi=
cal staff team can create custom notifications to send to patients' phones.=
 Does this seem like a worthwhile addition to you, or is it redundant since=
 the staff have access to the phone
 number of the patients which is also visible on the page?</div>
<div style=3D"font-family:Aptos,Aptos_EmbeddedFont,Aptos_MSFontService,Cali=
bri,Helvetica,sans-serif;font-size:12pt;color:rgb(0,0,0)">
<br>
</div>
<div style=3D"font-family:Aptos,Aptos_EmbeddedFont,Aptos_MSFontService,Cali=
bri,Helvetica,sans-serif;font-size:12pt;color:rgb(0,0,0)">
If you like this idea of the custom notifications, should the name of the s=
taff member that send the notification be visible as part of the custom not=
ification to the patient?</div>
<div style=3D"font-family:Aptos,Aptos_EmbeddedFont,Aptos_MSFontService,Cali=
bri,Helvetica,sans-serif;font-size:12pt;color:rgb(0,0,0)">
<br>
</div>
<div style=3D"font-family:Aptos,Aptos_EmbeddedFont,Aptos_MSFontService,Cali=
bri,Helvetica,sans-serif;font-size:12pt;color:rgb(0,0,0)">
Thanks again, and have a good weekend!</div>
<div style=3D"font-family:Aptos,Aptos_EmbeddedFont,Aptos_MSFontService,Cali=
bri,Helvetica,sans-serif;font-size:12pt;color:rgb(0,0,0)">
Jacob</div>
<div id=3D"m_1823689867367682542appendonsend"></div>
<hr style=3D"display:inline-block;width:98%">
<div id=3D"m_1823689867367682542divRplyFwdMsg" dir=3D"ltr"><font face=3D"Ca=
libri, sans-serif" style=3D"font-size:11pt" color=3D"#000000"><b>From:</b> =
Rogers, Jacob C &lt;<a href=3D"mailto:jrogers335@gatech.edu" target=3D"_bla=
nk">jrogers335@gatech.edu</a>&gt;<br>
<b>Sent:</b> Friday, March 1, 2024 5:27 PM<br>
<b>To:</b> <a href=3D"mailto:mulingg@gmail.com" target=3D"_blank">mulingg@g=
mail.com</a> &lt;<a href=3D"mailto:mulingg@gmail.com" target=3D"_blank">mul=
ingg@gmail.com</a>&gt;<br>
<b>Cc:</b> Storey, Edward C &lt;<a href=3D"mailto:edward.storey@gatech.edu"=
 target=3D"_blank">edward.storey@gatech.edu</a>&gt;; Fu, Michael D &lt;<a h=
ref=3D"mailto:mfu42@gatech.edu" target=3D"_blank">mfu42@gatech.edu</a>&gt;;=
 Avunuri, Sai Anoop &lt;<a href=3D"mailto:savunuri3@gatech.edu" target=3D"_=
blank">savunuri3@gatech.edu</a>&gt;; Song, Jaehoon &lt;<a href=3D"mailto:js=
ong421@gatech.edu" target=3D"_blank">jsong421@gatech.edu</a>&gt;<br>
<b>Subject:</b> Heart Disease Care App Project Question</font>
<div>&nbsp;</div>
</div>

<div dir=3D"ltr">
<div style=3D"font-family:Aptos,Aptos_EmbeddedFont,Aptos_MSFontService,Cali=
bri,Helvetica,sans-serif;font-size:12pt;color:rgb(0,0,0)">
Hi Muling,</div>
<div style=3D"font-family:Aptos,Aptos_EmbeddedFont,Aptos_MSFontService,Cali=
bri,Helvetica,sans-serif;font-size:12pt;color:rgb(0,0,0)">
<br>
</div>
<div style=3D"font-family:Aptos,Aptos_EmbeddedFont,Aptos_MSFontService,Cali=
bri,Helvetica,sans-serif;font-size:12pt;color:rgb(0,0,0)">
Happy March, hope you've had a good last week of February. This last sprint=
 of the project we have been working to develop the medical staff dashboard=
 and had a quick design question for you.</div>
<div style=3D"font-family:Aptos,Aptos_EmbeddedFont,Aptos_MSFontService,Cali=
bri,Helvetica,sans-serif;font-size:12pt;color:rgb(0,0,0)">
<br>
</div>
<div style=3D"font-family:Aptos,Aptos_EmbeddedFont,Aptos_MSFontService,Cali=
bri,Helvetica,sans-serif;font-size:12pt;color:rgb(0,0,0)">
In the main dashboard where the medical staff can see patients, we are impl=
ementing a priority feature where each patient is assigned a risk rating ba=
sed on a statistical analysis model we are developing that notices deviatio=
ns in weight. For this system, we
 currently plan on implementing a three-tier system:</div>
<div style=3D"font-family:Aptos,Aptos_EmbeddedFont,Aptos_MSFontService,Cali=
bri,Helvetica,sans-serif;font-size:12pt;color:rgb(0,0,0)">
<br>
</div>
<div style=3D"font-family:Aptos,Aptos_EmbeddedFont,Aptos_MSFontService,Cali=
bri,Helvetica,sans-serif;font-size:12pt;color:rgb(0,0,0)">
Green (representing no detectable risk patterns)</div>
<div style=3D"font-family:Aptos,Aptos_EmbeddedFont,Aptos_MSFontService,Cali=
bri,Helvetica,sans-serif;font-size:12pt;color:rgb(0,0,0)">
Yellow (representing some possible detected risk that should be reviewed by=
 staff)</div>
<div style=3D"font-family:Aptos,Aptos_EmbeddedFont,Aptos_MSFontService,Cali=
bri,Helvetica,sans-serif;font-size:12pt;color:rgb(0,0,0)">
Red (representing large, sudden deviation in weight or detected swelling)</=
div>
<div style=3D"font-family:Aptos,Aptos_EmbeddedFont,Aptos_MSFontService,Cali=
bri,Helvetica,sans-serif;font-size:12pt;color:rgb(0,0,0)">
<br>
</div>
<div style=3D"font-family:Aptos,Aptos_EmbeddedFont,Aptos_MSFontService,Cali=
bri,Helvetica,sans-serif;font-size:12pt;color:rgb(0,0,0)">
Each patient will have this color as a part of their information to improve=
 the efficiency&nbsp;of the system and ensure higher risk patients are view=
ed by medical staff first. Does this system sound sufficient to you, and co=
uld you think of any improvements?</div>
<div style=3D"font-family:Aptos,Aptos_EmbeddedFont,Aptos_MSFontService,Cali=
bri,Helvetica,sans-serif;font-size:12pt;color:rgb(0,0,0)">
<br>
</div>
<div style=3D"font-family:Aptos,Aptos_EmbeddedFont,Aptos_MSFontService,Cali=
bri,Helvetica,sans-serif;font-size:12pt;color:rgb(0,0,0)">
More generally, our progress on the project is up to date with the iteratio=
n plan and development is going smoothly. We're excited to show you all the=
 new features next time we meet.</div>
<div style=3D"font-family:Aptos,Aptos_EmbeddedFont,Aptos_MSFontService,Cali=
bri,Helvetica,sans-serif;font-size:12pt;color:rgb(0,0,0)">
<br>
</div>
<div style=3D"font-family:Aptos,Aptos_EmbeddedFont,Aptos_MSFontService,Cali=
bri,Helvetica,sans-serif;font-size:12pt;color:rgb(0,0,0)">
Thanks so much!</div>
<div style=3D"font-family:Aptos,Aptos_EmbeddedFont,Aptos_MSFontService,Cali=
bri,Helvetica,sans-serif;font-size:12pt;color:rgb(0,0,0)">
Jacob for GT Junior Design Team 3342</div>
</div>
</div>

</div></blockquote></div>

--000000000000f88e1a06152538a3--
